Published 13 days ago

Biogen stock rises on sales of groundbreaking Alzheimer's drug

Summary by Quartz

Biogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge, Massachusetts-based pharmaceutical company reported higher than expected sales of its groundbreaking Alzheimer’s drug Leqembi. Read more...

0 Articles

All

Left

Center

Right

Quartz

Biogen stock rises on sales of groundbreaking Alzheimer's drug

13 days ago·United States

Read Full Article

CTN News l Chiang Rai Times

Sales Of Biogen's Alzheimer's Drug Lead To Stock Rise

(CTN News) – In morning trading on Wednesday, Biogen stock spiked 5% to about $202 after the Cambridge, Massachusetts-based pharmaceutical company announced that its groundbreaking Alzheimer’s drug Leqembi exceeded sales expectations. It has been reported by FactSet that Leqembi generated $19 million in sales in the first quarter of 2024, which was higher than analysts’ […] The post Sales Of Biogen’s Alzheimer’s Drug Lead To Stock Rise appeared …

12 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.